Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)
Clinical trial NCT06550011 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06550011
- Sponsor
- Avirmax Biopharma Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-07
- Primary completion
- 2027-01-13
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.